Literature DB >> 27376719

Fluoroscopy versus ultrasonography guided mini-percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease.

Heyang Sun1, Ze Zhang2, Guanghao Huang1, Shaw P Wan1, Huade Chen1, Bolin He1, Jian Yuan1, Yongda Liu1.   

Abstract

The objective of the study was to compare the therapeutic outcomes between the ultrasonography-guided (USG) and the fluoroscopy-guided (FG) mini-percutaneous nephrolithotomy (MPCNL) for the treatment of large or complex upper urinary tract stones (S.T.O.N.E. scores 5-11) in patients with autosomal dominant polycystic kidney disease (ADPKD). 45 ADPKD patients who were suffering from large or complex upper urinary tract stones (S.T.O.N.E. scores 5-11, mean score 7.6) in 45 renal units were accrued into this retrospective study. They were treated by either USG (20 patients) or FG (25 patients) MPCNL in our center. The treatment results as well as the complications according to the modified Clavien system were assessed and compared. The FG MPCNL group had a higher success rate in accessing the targeted calyces than the USG MPCNL group (96 vs. 70 %, p = 0.048). There was no significant difference observed between the two groups with respect to the operative time, the mean hemoglobin drop, and the stone free rate. The overall operative complications and the perioperative blood transfusion rates were significantly higher in the USG than the FG MPCNL groups, 71.4 vs. 29.2 %, p = 0.011, and 35.7 vs. 4.2 %, p = 0.018, respectively. There was no significant difference between these two groups in terms of major complications (Clavien score 3a-4a) (p = 0.542). In our center, the FG MPCNL was a superior modality to the USG MPCNL in the treatment of large or complex kidney stones in the ADPKD patients. It resulted in higher successful calyceal punctures and less operative complications.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease; Fluoroscopy; Mini-percutaneous nephrolithotomy; Ultrasonography; Urolithiasis

Mesh:

Substances:

Year:  2016        PMID: 27376719     DOI: 10.1007/s00240-016-0901-x

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  20 in total

1.  A quest--halting the progression of autosomal dominant polycystic kidney disease.

Authors:  David H Ellison; Julie R Ingelfinger
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management.

Authors:  C S Ng; A Yost; S B Streem
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

Review 3.  Nephrolithiasis in autosomal dominant polycystic kidney disease.

Authors:  Uwais B Mufti; Sarath K Nalagatla
Journal:  J Endourol       Date:  2010-10       Impact factor: 2.942

4.  Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?

Authors:  Aneesh Srivastava; Rajesh Bansal; Alok Srivastava; Samit Chaturvedi; Priyadarshi Ranjan; M S Ansari; Abhishek Yadav; Rakesh Kapoor
Journal:  Int Urol Nephrol       Date:  2011-11-20       Impact factor: 2.370

5.  S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi.

Authors:  Zhamshid Okhunov; Justin I Friedlander; Arvin K George; Brian D Duty; Daniel M Moreira; Arun K Srinivasan; Joel Hillelsohn; Arthur D Smith; Zeph Okeke
Journal:  Urology       Date:  2013-03-26       Impact factor: 2.649

6.  Polycystic kidney disease with renal calculi treated by percutaneous nephrolithotomy: a report of 11 cases.

Authors:  Junhui Zhang; Jianzhong Zhang; Nianzeng Xing
Journal:  Urol Int       Date:  2014-01-29       Impact factor: 2.089

7.  Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones.

Authors:  Mohamed F Abdelhafez; Jens Bedke; Bastian Amend; Ehab ElGanainy; Hassan Aboulella; Magdy Elakkad; Udo Nagele; Arnulf Stenzl; David Schilling
Journal:  BJU Int       Date:  2012-04-30       Impact factor: 5.588

Review 8.  Renal stone disease in autosomal dominant polycystic kidney disease.

Authors:  V E Torres; D M Wilson; R R Hattery; J W Segura
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

9.  Safety and efficacy of minimally invasive percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease.

Authors:  Ming Lei; Wei Zhu; Shaw P Wan; Yongda Liu; Guohua Zeng; Jian Yuan
Journal:  J Endourol       Date:  2013-10-04       Impact factor: 2.942

10.  Percutaneous Nephrolithotomy in Autosomal Dominant Polycystic Kidney Disease: Is it Different from Percutaneous Nephrolithotomy in Normal Kidney?

Authors:  Vishwajeet Singh; Rahul Janak Sinha; Dheeraj Kumar Gupta
Journal:  Curr Urol       Date:  2013-07-28
View more
  1 in total

Review 1.  Efficacy and Safety of Surgical Kidney Stone Interventions in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review.

Authors:  Vinusha Kalatharan; Racquel Jandoc; Gary Grewal; Danielle M Nash; Blayne Welk; Sisira Sarma; York Pei; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.